These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21898448)

  • 1. Patient perceptions of factors leading to spasmodic dysphonia: a combined clinical experience of 350 patients.
    Childs L; Rickert S; Murry T; Blitzer A; Sulica L
    Laryngoscope; 2011 Oct; 121(10):2195-8. PubMed ID: 21898448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and demographics in patients with spasmodic dysphonia.
    Schweinfurth JM; Billante M; Courey MS
    Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of risk factors for spasmodic dysphonia: A comparison with other voice disorders.
    Tanner K; Roy N; Merrill RM; Sauder C; Houtz DR; Smith ME
    Laryngoscope; 2012 May; 122(5):1082-92. PubMed ID: 22253036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported impact of dysphonia in a primary care population: an epidemiological study.
    Cohen SM
    Laryngoscope; 2010 Oct; 120(10):2022-32. PubMed ID: 20830762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and protective factors for spasmodic dysphonia: a case-control investigation.
    Tanner K; Roy N; Merrill RM; Kimber K; Sauder C; Houtz DR; Doman D; Smith ME
    J Voice; 2011 Jan; 25(1):e35-46. PubMed ID: 20171836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal dystonia gravidarum: sudden onset of adductor spasmodic dysphonia in pregnancy.
    Ankola A; Sulica L; Murry T
    Laryngoscope; 2013 Dec; 123(12):3127-30. PubMed ID: 23712421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological aspects of adductor spasmodic dysphonia: a prospective population controlled questionnaire study.
    Kaptein AA; Hughes BM; Scharloo M; Hondebrink N; Langeveld TP
    Clin Otolaryngol; 2010 Feb; 35(1):31-8. PubMed ID: 20447160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME
    Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of voice therapy in hyperfunctional dysphonia in adult patients.
    Kandoğan T; Koç M; Aksoy G
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(4):198-202. PubMed ID: 19860634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward improved differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia.
    Roy N; Mauszycki SC; Merrill RM; Gouse M; Smith ME
    Folia Phoniatr Logop; 2007; 59(2):83-90. PubMed ID: 17337898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response.
    Tanner K; Roy N; Merrill RM; Sauder C; Houtz DR; Smith ME
    Ann Otol Rhinol Laryngol; 2011 Jul; 120(7):465-73. PubMed ID: 21859056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy.
    Zecchin M; Lenarda AD; Bonin M; Mazzone C; Zanchi C; Di Chiara C; Davanzo M; Scherl G; Sabbadini G; Sinagra G
    Ital Heart J; 2001 Mar; 2(3):213-21. PubMed ID: 11305533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is dysphonia due to allergic laryngitis being misdiagnosed as laryngopharyngeal reflux?
    Randhawa PS; Mansuri S; Rubin JS
    Logoped Phoniatr Vocol; 2010 Apr; 35(1):1-5. PubMed ID: 19551554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of 116 patients with non-organic voice disorders: efficacy of mental imagery and laryngeal shaking.
    Voerman MS; Langeveld AP; van Rossum MA
    J Laryngol Otol; 2009 May; 123(5):528-34. PubMed ID: 18761769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of acoustic analysis of the voice to diagnosis and treatment of functional dysphonia].
    Chernobel'skiĭ SI
    Vestn Otorinolaringol; 2009; (5):40-2. PubMed ID: 20037556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychological factors in spasmodic dysphonia].
    Kiese-Himmel C; Zwirner P
    Laryngorhinootologie; 1996 Jul; 75(7):397-402. PubMed ID: 8924167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.